E. Bowden

发表

Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells.

Rebecca Slack, Akira Myoui, Kenneth M. Yamada, 2006, Experimental cell research.

Anti-apoptotic Signaling of Pleiotrophin through Its Receptor, Anaplastic Lymphoma Kinase*

A. Wellstein, E. Bowden, G. Stoica, 2002, The Journal of Biological Chemistry.

Invadopodia: unique methods for measurement of extracellular matrix degradation in vitro.

P. Coopman, E. Bowden, S. Mueller, 2001, Methods in cell biology.

Advances in Brief Tyrosine Phosphorylation Mediates ConA-induced Membrane Type 1-Matrix Metalloproteinase Expression and Matrix Metalloproteinase-2 Activation in MDA-MB-231 Human Breast Carcinoma Cells 1

Hiroshi Sato, M. Seiki, E. Thompson, 2006 .

In Vitro Invasion Assays: Phagocytosis of the Extracellular Matrix

P. Coopman, E. Bowden, S. Mueller, 2000, Current protocols in cytometry.

Tyrosine phosphorylation mediates ConA-induced membrane type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in MDA-MB-231 human breast carcinoma cells.

H. Sato, Hiroshi Sato, M. Seiki, 1997, Cancer research.

Midkine Binds to Anaplastic Lymphoma Kinase (ALK) and Acts as a Growth Factor for Different Cell Types*

C. Powers, A. Wellstein, A. Riegel, 2002, The Journal of Biological Chemistry.

The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells

S. McLeskey, P. Mangeat, E. Basyuk, 2000, Nature.

An invasion-related complex of cortactin, paxillin and PKCμ associates with invadopodia at sites of extracellular matrix degradation

D. Thomas, R. Glazer, Emma T Bowden, 1999, Oncogene.

DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.

A. Harris, R. Poulsom, Herren Wu, 2011, Cancer research.

Pleiotrophin (PTN) Expression and Function and in the Mouse Mammary Gland and Mammary Epithelial Cells

A. Wellstein, A. Riegel, E. Bowden, 2012, PloS one.

Surface expression and CEA binding of hnRNP M4 protein in HT29 colon cancer cells.

H. Juhl, Jacqueline Sayyah, E. Bowden, 2005, Anticancer research.

Tumor and Stem Cell Biology DLL 4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo

A. Harris, R. Poulsom, Herren Wu, 2011 .

E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells.

Anton Wellstein, Richard Schlegel, A. Wellstein, 2006, Cancer research.

The RhoA-binding protein, Rhophilin-2, Regulates Actin Cytoskeleton Organization*

P. Burbelo, K. B. Bouker, E. Bowden, 2002, The Journal of Biological Chemistry.

Tetracycline-regulated expression of hammerhead ribozymes in vivo.

A. Riegel, E. Bowden, 2004, Methods in molecular biology.

Identification of the Fibroblast Growth Factor (FGF)-interacting Domain in a Secreted FGF-binding Protein by Phage Display*

Yumi Ueda, Kevin McDonnell, Anton Wellstein, 2006, Journal of Biological Chemistry.

Vascular leakage in chick embryos after expression of a secreted binding protein for fibroblast growth factors

A. Wellstein, A. Riegel, E. Bowden, 2005, Laboratory Investigation.

Structure and function of human Vps20 and Snf7 proteins.

P. Burbelo, E. Bowden, J. Peck, 2004, The Biochemical journal.

Expression of a fibroblast growth factor-binding protein during the development of adenocarcinoma of the pancreas and colon.

A. Maitra, A. Wellstein, A. Kuo, 2006, Cancer research.

Antagonistes et agonistes d'alk et applications

A. Wellstein, Herren Wu, S. Coats, 2006 .

430 Analysis of 2,700 Cancer Exomes to Identify Novel Cancer Drivers and Therapeutic Opportunities

Nickolay A. Khazanov, D. Rhodes, S. Tomlins, 2012 .

Invadopodia: unique methods for measurement of extracellular matrix degradation in vitro.

P. Coopman, E. Bowden, S. Mueller, 2001, Methods in cell biology.